Liver Disease Platform Add-ons | InSphero

The 3D InSight™ Human Liver Disease Discovery Platform is designed for the study of non-alcoholic fatty liver diseases (NAFLD) such as diet-induced steatosis, non-alcoholic steatohepatitis, and liver fibrosis. Platform add-ons include special kits for inducing the desired state, as well as assay kits that have been certified by our liver team for use with 3D InSight™ Human Liver Disease models.

3D InSight™ FFA-BSA Kit for liver steatosis induction

The 3D InSight™ FFA-BSA Kit contains conjugated, quality controlled, free fatty acids (FFA)
bound to bovine serum albumin (BSA) for in vitro studies with 3D InSight™ Human Liver Disease
Discovery Platform models. This kit is designed for efficient induction of steatosis to recapitulate
the fatty liver disease state. The bioavailable, conjugated FFA substrates are readily taken up,
metabolized and stored in primary human hepatocytes in our human liver microtissues models,
enabling the study of non-alcoholic fatty liver disease (NAFLD) and other dietary-induced liver
diseases.

FFA-BSA Kit for steatosis induction in human liver microtissues

FFA-BSA Kit Contents

Kit contains sufficient quantities to treat 4 x 96 microtissues.

  • BSA (FFA-free) vehicle control
  • BSA-coupled Oleate
  • BSA-coupled Palmitate

Delivered at -20° C; Available only when purchased with
3D InSight™ Microtissues.  Kit contains sufficient quantities to treat 4 x 96 microtissues.

Platform Components*

Catalog #Description
KT-03-300-023D InSight™ FFA-BSA Kit

* 3D InSight™ Liver Disease Discovery Platform Bundles are customized based on specific partner requirements. Available only when purchased as part of a liver disease model.

Request Additional Resources

Brochure: FFA-BSA Kit

Request
Human Liver in vitro NASH Model

Brochure: Human Liver NASH Model

Request
3D InSight Human Liver Fibrosis Model Brochure

Brochure: Human Liver Fibrosis Model

Request

Find out how you can accelerate anti-NASH and anti-fibrosis

drug discovery with an advanced 3D liver disease models

Get Started